Skip to main content
main-content
Erschienen in: NeuroTransmitter 9/2015

08.09.2015 | Zertifizierte Fortbildung

Vermutlich oft gesehen, aber nur selten diagnostiziert

Neurologische und psychiatrische Symptome der systemischen MCAD

verfasst von: Dr. med. Dieter Pöhlau, Prof. Dr. med. Martin Raithel, PD Dr. rer. nat. Britta Haenisch, Dipl.-Phys. Sabrina Harzer, Prof. Dr. med. Gerhard J. Molderings

Erschienen in: NeuroTransmitter | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

In der Neurologie und Psychiatrie finden sich oft Patienten mit zentralnervösen Symptomen, die dauerhaft oder episodisch unter vielen anderen Beschwerden leiden, deren Ursache trotz umfangreicher Suche unklar bleibt und deren symptomatische Therapien weitgehend frustran verlaufen. Eine systemische Mastzellaktivierungserkrankung (MCAD) wird nur selten in die differenzialdiagnostischen Überlegungen einbezogen.
Literatur
1.
Zurück zum Zitat Gri G, Frossi B, D’Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C. Mast cell: an emerging partner in immune interaction. Front Immunol 2012;3:120. PubMedCentralCrossRefPubMed Gri G, Frossi B, D’Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C. Mast cell: an emerging partner in immune interaction. Front Immunol 2012;3:120. PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Lundequist A, Pejler G. Biological implications of preformed mast cell mediators. Cell Mol Life Sci 2011;68:965–75. CrossRefPubMed Lundequist A, Pejler G. Biological implications of preformed mast cell mediators. Cell Mol Life Sci 2011;68:965–75. CrossRefPubMed
3.
Zurück zum Zitat Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React 1996;18:1–21. PubMed Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React 1996;18:1–21. PubMed
4.
Zurück zum Zitat Silverman AJ, Sutherland AK, Wilhelm M, Silver R. Mast cells migrate from blood to brain. J Neurosci 2000;20:401–8. PubMed Silverman AJ, Sutherland AK, Wilhelm M, Silver R. Mast cells migrate from blood to brain. J Neurosci 2000;20:401–8. PubMed
5.
Zurück zum Zitat Khalil M, Ronda J, Weintraub M, Jain K, Silver R, Silverman AJ. Brain mast cell relationship to neurovasculature during development. Brain Res 2007;1171:18–29. PubMedCentralCrossRefPubMed Khalil M, Ronda J, Weintraub M, Jain K, Silver R, Silverman AJ. Brain mast cell relationship to neurovasculature during development. Brain Res 2007;1171:18–29. PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Porzionato A, Macchi V, Parenti A, De Caro R. The distribution of mast cells in the human area postrema. J Anat;204:141–7. Porzionato A, Macchi V, Parenti A, De Caro R. The distribution of mast cells in the human area postrema. J Anat;204:141–7.
7.
Zurück zum Zitat Turygin VV, Babik TM, Boyakov AA. Characteristics of mast cells in the choroid plexus of the ventricles of the human brain in aging. Neurosci Behav Physiol 2005;35:909–11. CrossRefPubMed Turygin VV, Babik TM, Boyakov AA. Characteristics of mast cells in the choroid plexus of the ventricles of the human brain in aging. Neurosci Behav Physiol 2005;35:909–11. CrossRefPubMed
8.
Zurück zum Zitat Maslinska D, Laure-Kamionowska M, Gujski M, Ciurzynska G, Wojtecka-Lukasik E. Post-infectional distribution and phenotype of mast cells penetrating human brains. Inflamm Res 2005; 54, Suppl.1:15–16. CrossRef Maslinska D, Laure-Kamionowska M, Gujski M, Ciurzynska G, Wojtecka-Lukasik E. Post-infectional distribution and phenotype of mast cells penetrating human brains. Inflamm Res 2005; 54, Suppl.1:15–16. CrossRef
9.
Zurück zum Zitat Pang X, Letourneau R, Rozniecki JJ, Wang L, Theoharides TC. Definitive characterization of rat hypothalamic mast cells. Neuroscience 1996;73:889–902. CrossRefPubMed Pang X, Letourneau R, Rozniecki JJ, Wang L, Theoharides TC. Definitive characterization of rat hypothalamic mast cells. Neuroscience 1996;73:889–902. CrossRefPubMed
10.
Zurück zum Zitat Shanas U, Bhasin R, Sutherland AK, Silverman AJ, Silver R. Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J Neuroimmunol 1998;90:207–11. CrossRefPubMed Shanas U, Bhasin R, Sutherland AK, Silverman AJ, Silver R. Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J Neuroimmunol 1998;90:207–11. CrossRefPubMed
11.
Zurück zum Zitat Dubayle D, Malissin I, Menetrey D. Differential effects of two analegesic drugs, morphine, chlorhydrate and acetylsalicylic acid, on thalamic mast cell numbers in rat. J Neuroimmunol 2005;169:106–15. CrossRefPubMed Dubayle D, Malissin I, Menetrey D. Differential effects of two analegesic drugs, morphine, chlorhydrate and acetylsalicylic acid, on thalamic mast cell numbers in rat. J Neuroimmunol 2005;169:106–15. CrossRefPubMed
12.
Zurück zum Zitat Kovacs P, Hernadi I, Wilhelm M. Mast cells modulate maintained neuronal activity in the thalamus in vivo. J Neuroimmunol 2006;171:1–7. CrossRefPubMed Kovacs P, Hernadi I, Wilhelm M. Mast cells modulate maintained neuronal activity in the thalamus in vivo. J Neuroimmunol 2006;171:1–7. CrossRefPubMed
13.
Zurück zum Zitat Ito A, Hagiyama M, Oonuma J. Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1. J Smooth Muscle Res 2008;44:83–93. CrossRefPubMed Ito A, Hagiyama M, Oonuma J. Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1. J Smooth Muscle Res 2008;44:83–93. CrossRefPubMed
14.
Zurück zum Zitat Nautiyal KM, McKellar H, Silverman AJ, Silver R. Mast cells are necessary for the hypothermic response to LPS-induced sepsis. Am J Physiol Regul Integr Comp Physiol 2009;296: R595–R602. PubMedCentralCrossRefPubMed Nautiyal KM, McKellar H, Silverman AJ, Silver R. Mast cells are necessary for the hypothermic response to LPS-induced sepsis. Am J Physiol Regul Integr Comp Physiol 2009;296: R595–R602. PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Goldschmidt RC, Hough LB, Glick SD. Rat brain mast cells: contribution to brain histamine levels. J Neurochem 1985;44:1943–7. CrossRefPubMed Goldschmidt RC, Hough LB, Glick SD. Rat brain mast cells: contribution to brain histamine levels. J Neurochem 1985;44:1943–7. CrossRefPubMed
16.
Zurück zum Zitat Zarrindast MR, Valizadegan F, Rostami P, Rezayof A. Histaminergic system of the lateral septum in the modulation of anxiety-like behaviour in rats. Eur J Pharmacol 2008;583:108–14. CrossRefPubMed Zarrindast MR, Valizadegan F, Rostami P, Rezayof A. Histaminergic system of the lateral septum in the modulation of anxiety-like behaviour in rats. Eur J Pharmacol 2008;583:108–14. CrossRefPubMed
17.
Zurück zum Zitat Dere E, Zlomuzica A, De Souza-Silva MA, Ruocco LA, Sadile AG, Huston JP. Neuronal histamine and the interplay of memory, reinforcement and emotions. Behav Brain Res 2010;215:209–20. CrossRefPubMed Dere E, Zlomuzica A, De Souza-Silva MA, Ruocco LA, Sadile AG, Huston JP. Neuronal histamine and the interplay of memory, reinforcement and emotions. Behav Brain Res 2010;215:209–20. CrossRefPubMed
18.
Zurück zum Zitat Gianlorenço AC, Serafim KR, Canto-de-Souza A, Mattioli R. Emotional memory consolidation impairment induced by histamine is mediated by H(1) but not H(2) receptors. Brain Res Bull 2012; 89:197–202. CrossRefPubMed Gianlorenço AC, Serafim KR, Canto-de-Souza A, Mattioli R. Emotional memory consolidation impairment induced by histamine is mediated by H(1) but not H(2) receptors. Brain Res Bull 2012; 89:197–202. CrossRefPubMed
19.
Zurück zum Zitat Asadi S, Zhang B, Alysandratos K, Angelidou A, Vasiadi M, Theoharides T. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Allergy Clin Immunol 2011;127, Suppl 2:AB162. CrossRef Asadi S, Zhang B, Alysandratos K, Angelidou A, Vasiadi M, Theoharides T. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Allergy Clin Immunol 2011;127, Suppl 2:AB162. CrossRef
20.
Zurück zum Zitat Alysandratos KD, Asadi S, Angelidou A, Zhang B, Sismanopoulos N, Yang H, Critchfield A, Theoharides TC. Neurotensin and CRH interactions augment human mast cell activation. PLoS One 2012;7:e48934. PubMedCentralCrossRefPubMed Alysandratos KD, Asadi S, Angelidou A, Zhang B, Sismanopoulos N, Yang H, Critchfield A, Theoharides TC. Neurotensin and CRH interactions augment human mast cell activation. PLoS One 2012;7:e48934. PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Overman EL, Rivier JE, Moeser AJ. CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-a. PLoS One 2012;7:e39935. PubMedCentralCrossRefPubMed Overman EL, Rivier JE, Moeser AJ. CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-a. PLoS One 2012;7:e39935. PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Theoharides TC, Petra AI, Stewart JM, Tsilioni I, Panagiotidou S, Akin C. High serum corticotropin-releasing hormone (CRH) and bone marrow mast cell CRH receptor expression in a mastocytosis patient. J Allergy Clin Immunol 2014;134:1197–9. CrossRefPubMed Theoharides TC, Petra AI, Stewart JM, Tsilioni I, Panagiotidou S, Akin C. High serum corticotropin-releasing hormone (CRH) and bone marrow mast cell CRH receptor expression in a mastocytosis patient. J Allergy Clin Immunol 2014;134:1197–9. CrossRefPubMed
23.
Zurück zum Zitat Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008;123:398–410. PubMedCentralCrossRefPubMed Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008;123:398–410. PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445–52. CrossRefPubMed Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445–52. CrossRefPubMed
25.
Zurück zum Zitat McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009;33:355–66. CrossRefPubMed McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 2009;33:355–66. CrossRefPubMed
26.
Zurück zum Zitat Costa-Pinto FA, Basso AS, de Sa-Rocha LC, Britto LRG, Russo M, Palermo-Neto J. Neural correlates of IgE-mediated allergy. NY Acad Sci 2006;1088:116–31. CrossRef Costa-Pinto FA, Basso AS, de Sa-Rocha LC, Britto LRG, Russo M, Palermo-Neto J. Neural correlates of IgE-mediated allergy. NY Acad Sci 2006;1088:116–31. CrossRef
27.
Zurück zum Zitat Nautiyal KM. Mast cells affect brain physiology and behaviour. 2011, Thesis. Nautiyal KM. Mast cells affect brain physiology and behaviour. 2011, Thesis.
28.
Zurück zum Zitat Silver R, Curley JP. Mast cells on the mind: new insights and opportunities. Trends Neurosci 2013;36:513–21. CrossRefPubMed Silver R, Curley JP. Mast cells on the mind: new insights and opportunities. Trends Neurosci 2013;36:513–21. CrossRefPubMed
30.
Zurück zum Zitat Nelissen S, Lemmens E, Geurts N, Kramer P, Maurer M, Hendriks J, Hendrix S. The role of mast cells in neuroinflammation. Acta Neuropathol 2013;125:637–50. CrossRefPubMed Nelissen S, Lemmens E, Geurts N, Kramer P, Maurer M, Hendriks J, Hendrix S. The role of mast cells in neuroinflammation. Acta Neuropathol 2013;125:637–50. CrossRefPubMed
31.
Zurück zum Zitat Xanthos DN, Gaderer S, Drdla R, Nuro E, Abramova A, Ellmeier W, Sandkühler J. Central nervous system mast cells in peripheral inflammatory nociception. Mol Pain 2011;7:42. PubMedCentralCrossRefPubMed Xanthos DN, Gaderer S, Drdla R, Nuro E, Abramova A, Ellmeier W, Sandkühler J. Central nervous system mast cells in peripheral inflammatory nociception. Mol Pain 2011;7:42. PubMedCentralCrossRefPubMed
32.
33.
Zurück zum Zitat Demir IE, Schorn S, Schremmer-Danninger E, Wang K, Kehl T, Giese NA, Algül H, Friess H, Ceyhan GO. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One 2013;8:e60529. PubMedCentralCrossRefPubMed Demir IE, Schorn S, Schremmer-Danninger E, Wang K, Kehl T, Giese NA, Algül H, Friess H, Ceyhan GO. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One 2013;8:e60529. PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Molderings GJ, Homann J, Brettner S, Raithel M, Frieling T. Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie. Dtsch Med Wochenschr. 2014;139:1523–34 CrossRefPubMed Molderings GJ, Homann J, Brettner S, Raithel M, Frieling T. Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie. Dtsch Med Wochenschr. 2014;139:1523–34 CrossRefPubMed
35.
Zurück zum Zitat Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol 2011;4:10. PubMedCentralCrossRefPubMed Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol 2011;4:10. PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Molderings GJ, Haenisch B, Bogdanow M, Fimmers R, Nöthen MM. Familial occurrence of systemic mast cell activation disease. PLoS One 2013;8:e76241. PubMedCentralCrossRefPubMed Molderings GJ, Haenisch B, Bogdanow M, Fimmers R, Nöthen MM. Familial occurrence of systemic mast cell activation disease. PLoS One 2013;8:e76241. PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Lucas HJ, Brauch CM, Settas L, Theoharides TC. Fibromyalgia - new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 2006;19: 5–9. PubMed Lucas HJ, Brauch CM, Settas L, Theoharides TC. Fibromyalgia - new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 2006;19: 5–9. PubMed
38.
Zurück zum Zitat Blanco I, Béritze N, Argüelles M, Cárcaba V, Fernández F, Janciauskiene S, Oikonomopoulou K, de Serres FJ, Fernández-Bustillo E, Hollenberg MD. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 2010;29:1403–12. CrossRefPubMed Blanco I, Béritze N, Argüelles M, Cárcaba V, Fernández F, Janciauskiene S, Oikonomopoulou K, de Serres FJ, Fernández-Bustillo E, Hollenberg MD. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 2010;29:1403–12. CrossRefPubMed
39.
Zurück zum Zitat Maeshima E, Furukawa K. A case of fibromyalgia syndrome with anaphylaxis induced by intradermal injection of purified protein derivative. Mod Rheumatol 2013;23:593–6. CrossRefPubMed Maeshima E, Furukawa K. A case of fibromyalgia syndrome with anaphylaxis induced by intradermal injection of purified protein derivative. Mod Rheumatol 2013;23:593–6. CrossRefPubMed
40.
Zurück zum Zitat Santos J, Guilarte M, Alonso C, Malagelada JR. Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol 2005;40:129–40. CrossRefPubMed Santos J, Guilarte M, Alonso C, Malagelada JR. Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol 2005;40:129–40. CrossRefPubMed
41.
Zurück zum Zitat Klooker TK, Braak B, Koopman KE, Welting O, Wouters MM, van der Heide S, Schemann M, Bischoff SC, van den Wijngaard RM, Boeckxstaens GE. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010;59:1213–21. CrossRefPubMed Klooker TK, Braak B, Koopman KE, Welting O, Wouters MM, van der Heide S, Schemann M, Bischoff SC, van den Wijngaard RM, Boeckxstaens GE. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010;59:1213–21. CrossRefPubMed
42.
Zurück zum Zitat Frieling T, Meis K, Kolck UW, Homann J, Hülsdonk A, Haars U, Hertfelder HJ, Oldenburg J, Seidel H, Molderings GJ. Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z Gastroenterol 2011;49:191–4. CrossRefPubMed Frieling T, Meis K, Kolck UW, Homann J, Hülsdonk A, Haars U, Hertfelder HJ, Oldenburg J, Seidel H, Molderings GJ. Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome. Z Gastroenterol 2011;49:191–4. CrossRefPubMed
43.
Zurück zum Zitat Haenisch B, Nöthen MM, Molderings GJ. Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunology 2012;137:197–205. PubMedCentralCrossRefPubMed Haenisch B, Nöthen MM, Molderings GJ. Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics. Immunology 2012;137:197–205. PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009;113:5727–36. CrossRefPubMed Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009;113:5727–36. CrossRefPubMed
45.
Zurück zum Zitat Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmérini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A. Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS ONE 2008;3:e2266. PubMedCentralCrossRefPubMed Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmérini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A. Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS ONE 2008;3:e2266. PubMedCentralCrossRefPubMed
46.
Zurück zum Zitat Moura DS, Sultan S, Georgin-Lavialle S, Pillet N, Montestruc F, Gineste P, Barete S, Damaj G, Moussy A, Lortholary O, Hermine O. Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy. PLoS ONE 2011;6:e26375. PubMedCentralCrossRefPubMed Moura DS, Sultan S, Georgin-Lavialle S, Pillet N, Montestruc F, Gineste P, Barete S, Damaj G, Moussy A, Lortholary O, Hermine O. Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy. PLoS ONE 2011;6:e26375. PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Moura DS, Sultan S, Georgin-Lavialle S, Barete S, Lortholary O, Gaillard R, Hermine O. Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS ONE 2012;7:e39468. PubMedCentralCrossRefPubMed Moura DS, Sultan S, Georgin-Lavialle S, Barete S, Lortholary O, Gaillard R, Hermine O. Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS ONE 2012;7:e39468. PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Rogers MP, Bloomingdale K, Murawski BJ, Soter NA, Reich P, Austen KF. Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosom Med 1986;48: 437–47. CrossRefPubMed Rogers MP, Bloomingdale K, Murawski BJ, Soter NA, Reich P, Austen KF. Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosom Med 1986;48: 437–47. CrossRefPubMed
49.
Zurück zum Zitat Tajima Y, Hamada K, Houzenn H. Sequential magnetic resonance features of encephalopathy induced by systemic mastocytosis. Intern Med 1994;33:23–6. CrossRefPubMed Tajima Y, Hamada K, Houzenn H. Sequential magnetic resonance features of encephalopathy induced by systemic mastocytosis. Intern Med 1994;33:23–6. CrossRefPubMed
50.
Zurück zum Zitat Jost E, Michaux L, Vanden Abeele M, Boland B, Latinne D, Godfraind C, Scheiff JM, Vaerman JL, Lecouvet F, Ferrant A. Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia, and brain damage. Ann Hematol 2001;80:302–7. CrossRefPubMed Jost E, Michaux L, Vanden Abeele M, Boland B, Latinne D, Godfraind C, Scheiff JM, Vaerman JL, Lecouvet F, Ferrant A. Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia, and brain damage. Ann Hematol 2001;80:302–7. CrossRefPubMed
51.
Zurück zum Zitat Boncoraglio GB, Brucato A, Carriero MR, Maccagnano E, Robbiolo L, Scappatura LO, Soligo D, Parati EA. Systemic mastocytosis: a potential neurologic emergency. Neurology 2005;65:332–333. CrossRefPubMed Boncoraglio GB, Brucato A, Carriero MR, Maccagnano E, Robbiolo L, Scappatura LO, Soligo D, Parati EA. Systemic mastocytosis: a potential neurologic emergency. Neurology 2005;65:332–333. CrossRefPubMed
52.
Zurück zum Zitat Smith JH, Butterfield JH, Pardanani A, Deluca GC, Cutrer FM. Neurologic symptoms and diagnosis in adults with mast cell disease. Clin Neurol Neurosurg 2011;113:570–4. CrossRefPubMed Smith JH, Butterfield JH, Pardanani A, Deluca GC, Cutrer FM. Neurologic symptoms and diagnosis in adults with mast cell disease. Clin Neurol Neurosurg 2011;113:570–4. CrossRefPubMed
53.
Zurück zum Zitat Afrin LB. Sclerosing mediastinitis and mast cell activation syndrome. Pathol Res Pract 2012;208:181–5. CrossRefPubMed Afrin LB. Sclerosing mediastinitis and mast cell activation syndrome. Pathol Res Pract 2012;208:181–5. CrossRefPubMed
54.
Zurück zum Zitat Kushnir-Sukhov NM, Brittain E, Scott L, Metcalfe DD. Clinical correlates of blood serotonin levels in patients with mastocytosis. Eur J Clin Invest 2008;38:953–8. PubMedCentralCrossRefPubMed Kushnir-Sukhov NM, Brittain E, Scott L, Metcalfe DD. Clinical correlates of blood serotonin levels in patients with mastocytosis. Eur J Clin Invest 2008;38:953–8. PubMedCentralCrossRefPubMed
55.
Zurück zum Zitat Georgin-Lavialle S, Moura DS, Bruneau J, Chauvet-Gélinier JC, Damaj G, Soucie E, Barete S, Gacon AL, Grandpeix-Guyodo C, Suarez F, Launay JM, Durieu I, Esparcieux A, Guichard I, Sparsa A, Nicolini F, Gennes CD, Trojak B, Haffen E, Vandel P, Lortholary O, Dubreuil P, Bonin B, Sultan S, Teyssier JR, Hermine O. Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress. Brain Behav Immun 2014;35:51–7. CrossRefPubMed Georgin-Lavialle S, Moura DS, Bruneau J, Chauvet-Gélinier JC, Damaj G, Soucie E, Barete S, Gacon AL, Grandpeix-Guyodo C, Suarez F, Launay JM, Durieu I, Esparcieux A, Guichard I, Sparsa A, Nicolini F, Gennes CD, Trojak B, Haffen E, Vandel P, Lortholary O, Dubreuil P, Bonin B, Sultan S, Teyssier JR, Hermine O. Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress. Brain Behav Immun 2014;35:51–7. CrossRefPubMed
56.
Zurück zum Zitat Ashina S, Ashina M. Headache in systemic mastocytosis: a case report with pathophysiological considerations. Cephalalgia 2004;25:314–6. CrossRef Ashina S, Ashina M. Headache in systemic mastocytosis: a case report with pathophysiological considerations. Cephalalgia 2004;25:314–6. CrossRef
57.
Zurück zum Zitat Maintz L, Wardelmann E, Walgenbach K, Fimmers R, Bieber T, Raap U, Novak N. Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis. Allergy 2011;66:862–9. CrossRefPubMed Maintz L, Wardelmann E, Walgenbach K, Fimmers R, Bieber T, Raap U, Novak N. Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis. Allergy 2011;66:862–9. CrossRefPubMed
58.
Zurück zum Zitat Peng WM, Maintz L, Allam JP, Raap U, Gütgemann I, Kirfel J, Wardelmann E, Perner S, Zhao W, Fimmers R, Walgenbach K, Oldenburg J, Schwartz LB, Novak N. Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis. Blood 2013;122:1779–88. CrossRefPubMed Peng WM, Maintz L, Allam JP, Raap U, Gütgemann I, Kirfel J, Wardelmann E, Perner S, Zhao W, Fimmers R, Walgenbach K, Oldenburg J, Schwartz LB, Novak N. Increased circulating levels of neurotrophins and elevated expression of their high-affinity receptors on skin and gut mast cells in mastocytosis. Blood 2013;122:1779–88. CrossRefPubMed
59.
Zurück zum Zitat Church MK, Gradidge CF. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol 1980;69:663–7. PubMedCentralCrossRefPubMed Church MK, Gradidge CF. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol 1980;69:663–7. PubMedCentralCrossRefPubMed
60.
Zurück zum Zitat Haenisch B, Huber M, Wilhelm T, Steffens M, Molderings GJ. Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling. Life Sci 2013;92:345–51. CrossRefPubMed Haenisch B, Huber M, Wilhelm T, Steffens M, Molderings GJ. Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling. Life Sci 2013;92:345–51. CrossRefPubMed
61.
Zurück zum Zitat Hoffmann K, Xifró RA, Hartweg JL, Spitzlei P, Meis K, Molderings GJ, von Kügelgen I. Inhibitory effects of benzodiazepines on the adenosine A(2B) receptor mediated secretion of interleukin-8 in human mast cells. Eur J Pharmacol 2013;700:152–8. CrossRefPubMed Hoffmann K, Xifró RA, Hartweg JL, Spitzlei P, Meis K, Molderings GJ, von Kügelgen I. Inhibitory effects of benzodiazepines on the adenosine A(2B) receptor mediated secretion of interleukin-8 in human mast cells. Eur J Pharmacol 2013;700:152–8. CrossRefPubMed
62.
Zurück zum Zitat Yousefi OS, Wilhelm T, Maschke-Neuß K, Kuhny M, Martin C, Molderings GJ, Kratz F, Hildenbrand B, Huber M. The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions. Cell Commun Signal 2013;11:13. PubMedCentralCrossRefPubMed Yousefi OS, Wilhelm T, Maschke-Neuß K, Kuhny M, Martin C, Molderings GJ, Kratz F, Hildenbrand B, Huber M. The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions. Cell Commun Signal 2013;11:13. PubMedCentralCrossRefPubMed
63.
Zurück zum Zitat Angelidou A, Asadi S, Alysandratos KD, Karagkouni A, Kourembanas S, Theoharides TC. Perinatal stress, brain inflammation and risk of autism - review and proposal. BMC Pediatr 2012;12:89. PubMedCentralCrossRefPubMed Angelidou A, Asadi S, Alysandratos KD, Karagkouni A, Kourembanas S, Theoharides TC. Perinatal stress, brain inflammation and risk of autism - review and proposal. BMC Pediatr 2012;12:89. PubMedCentralCrossRefPubMed
64.
65.
Zurück zum Zitat Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, Sonders MS, Kanter E, Castagna C, Yamamoto A, Yue Z, Arancio O, Peterson BS, Champagne F, Dwork AJ, Goldman J, Sulzer D. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014;83:1–13 CrossRef Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, Sonders MS, Kanter E, Castagna C, Yamamoto A, Yue Z, Arancio O, Peterson BS, Champagne F, Dwork AJ, Goldman J, Sulzer D. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014;83:1–13 CrossRef
66.
Zurück zum Zitat Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev 2005;49:65–76. CrossRefPubMed Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev 2005;49:65–76. CrossRefPubMed
67.
Zurück zum Zitat Levy D, Burstein R, Strassman AM. Mast cell involvement in the pathophysiology of migraine headache: a hypothesis. Headache 2006;46 Suppl 1:S13–S18. CrossRefPubMed Levy D, Burstein R, Strassman AM. Mast cell involvement in the pathophysiology of migraine headache: a hypothesis. Headache 2006;46 Suppl 1:S13–S18. CrossRefPubMed
68.
Zurück zum Zitat Yeom JS, Choi MB, Seo JH, Park JS, Lim JY, Park CH, Woo HO, Youn HS, Ko GH, Baik SC, Lee WK, Cho MJ, Rhee KH. Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia. Cephalalgia 2013;33:323–9. CrossRefPubMed Yeom JS, Choi MB, Seo JH, Park JS, Lim JY, Park CH, Woo HO, Youn HS, Ko GH, Baik SC, Lee WK, Cho MJ, Rhee KH. Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia. Cephalalgia 2013;33:323–9. CrossRefPubMed
69.
Zurück zum Zitat Smith JH, Butterfield JH, Cutrer FM. Primary headache syndromes in systemic mastocytosis. Cephalalgia 2011;31:1522–31. CrossRefPubMed Smith JH, Butterfield JH, Cutrer FM. Primary headache syndromes in systemic mastocytosis. Cephalalgia 2011;31:1522–31. CrossRefPubMed
70.
Zurück zum Zitat Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 2012;26:3103–17. CrossRefPubMed Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 2012;26:3103–17. CrossRefPubMed
71.
Zurück zum Zitat Yasuda M, Kido K, Ohtani N, Masaki E. Mast cell stabilization promotes antinociceptive effects in a mouse model of postoperative pain. J Pain Res 2013;6:161–6. PubMedCentralPubMed Yasuda M, Kido K, Ohtani N, Masaki E. Mast cell stabilization promotes antinociceptive effects in a mouse model of postoperative pain. J Pain Res 2013;6:161–6. PubMedCentralPubMed
72.
Zurück zum Zitat Li WW, Guo TZ, Liang DY, Sun Y, Kingery WS, Clark JD. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology 2012;116:882–95. PubMedCentralCrossRefPubMed Li WW, Guo TZ, Liang DY, Sun Y, Kingery WS, Clark JD. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology 2012;116:882–95. PubMedCentralCrossRefPubMed
73.
Zurück zum Zitat Dirckx M, Groeneweg G, van Daele PL, Stronks DL, Huygen FJ. Mast Cells: A New arget in the Treatment of Complex Regional Pain Syndrome? Pain Pract 2013;13:599–603. CrossRefPubMed Dirckx M, Groeneweg G, van Daele PL, Stronks DL, Huygen FJ. Mast Cells: A New arget in the Treatment of Complex Regional Pain Syndrome? Pain Pract 2013;13:599–603. CrossRefPubMed
74.
Zurück zum Zitat Riccardi VM. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser 1981;17:129–45. PubMed Riccardi VM. Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser 1981;17:129–45. PubMed
75.
Zurück zum Zitat Schmitz SD. Die Rolle der Mastzelle beim überschießenden Wachstum traumatisierter dermaler Neurofibrome. Dissertation, Berlin 2009. Schmitz SD. Die Rolle der Mastzelle beim überschießenden Wachstum traumatisierter dermaler Neurofibrome. Dissertation, Berlin 2009.
76.
Zurück zum Zitat Bornstein J, Cohen Y, Zarfati D, Sela S, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol 2008;27:136–41. CrossRefPubMed Bornstein J, Cohen Y, Zarfati D, Sela S, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol 2008;27:136–41. CrossRefPubMed
77.
Zurück zum Zitat Afrin L. Presentation, diagnosis, and management of mast cell activation syndrome. In Mast Cells: Phenotypic features, biological functions, and role in immunity. Nova Science Publishers, Happauge, NY, 2013: pp. 155–231. Afrin L. Presentation, diagnosis, and management of mast cell activation syndrome. In Mast Cells: Phenotypic features, biological functions, and role in immunity. Nova Science Publishers, Happauge, NY, 2013: pp. 155–231.
78.
79.
Zurück zum Zitat Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade’s clinical experience at the brigham and the women’s hospital. Invest Dermatol 1991;96:5S–14S. CrossRef Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade’s clinical experience at the brigham and the women’s hospital. Invest Dermatol 1991;96:5S–14S. CrossRef
81.
Zurück zum Zitat Dasanu CA, Davis LK, Bauer F. Aleukemic leukemia presenting with paranoid psychosis. Conn Med 2013;77:537–9. PubMed Dasanu CA, Davis LK, Bauer F. Aleukemic leukemia presenting with paranoid psychosis. Conn Med 2013;77:537–9. PubMed
82.
Zurück zum Zitat Undem BJ, Taylor-Clark T. Mechanisms underlying the neuronal-based symptoms of allergy. J Allergy Clin Immunol 2014;133:1521–34. CrossRefPubMed Undem BJ, Taylor-Clark T. Mechanisms underlying the neuronal-based symptoms of allergy. J Allergy Clin Immunol 2014;133:1521–34. CrossRefPubMed
83.
Zurück zum Zitat Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37:435–53. CrossRefPubMed Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007;37:435–53. CrossRefPubMed
84.
Zurück zum Zitat Yuan H, Zhu X, Zhou S, Chen Q, Zhu X, Ma X, He X, Tian M, Shi X. Role of mast cell activation in inducing microglial cells to release neurotrophin. J Neurosci Res 2010;88:1348–54. PubMed Yuan H, Zhu X, Zhou S, Chen Q, Zhu X, Ma X, He X, Tian M, Shi X. Role of mast cell activation in inducing microglial cells to release neurotrophin. J Neurosci Res 2010;88:1348–54. PubMed
85.
Zurück zum Zitat Schramm A, Grunewald S, Lorenz R, Classen J, Naumann M. Parkinsonism due to bilateral basal ganglia lesions following mastocytosis-induced hypoxia. J Neurol 2004;251:1270–2. CrossRefPubMed Schramm A, Grunewald S, Lorenz R, Classen J, Naumann M. Parkinsonism due to bilateral basal ganglia lesions following mastocytosis-induced hypoxia. J Neurol 2004;251:1270–2. CrossRefPubMed
86.
Zurück zum Zitat Berlin G, Enerbäck L. Non-differential inhibition of histamine and serotonin release from mast cells by amitriptyline. Agents Actions 1986;18:89–91. CrossRefPubMed Berlin G, Enerbäck L. Non-differential inhibition of histamine and serotonin release from mast cells by amitriptyline. Agents Actions 1986;18:89–91. CrossRefPubMed
87.
Zurück zum Zitat Sano T, Uchida MK, Suzuki-Nishimura T. The effects of clozapine on rat mast cells are different from those of benzodiazepines. Gen Pharmacol 1990;21:559–61. CrossRefPubMed Sano T, Uchida MK, Suzuki-Nishimura T. The effects of clozapine on rat mast cells are different from those of benzodiazepines. Gen Pharmacol 1990;21:559–61. CrossRefPubMed
88.
Zurück zum Zitat Seol IW, Kuo NY, Kim KM. Effects of dopaminergic drugs on the mast cell degranulation and nitric oxide generation in RAW 264.7 cells. Arch Pharm Res 2004;27:94–8. CrossRefPubMed Seol IW, Kuo NY, Kim KM. Effects of dopaminergic drugs on the mast cell degranulation and nitric oxide generation in RAW 264.7 cells. Arch Pharm Res 2004;27:94–8. CrossRefPubMed
89.
Zurück zum Zitat Laengle UW, Markstein R, Pralet D, Seewald W, Roman D. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist an dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Exp Eye Res 2006;83:1335–9. CrossRefPubMed Laengle UW, Markstein R, Pralet D, Seewald W, Roman D. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist an dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Exp Eye Res 2006;83:1335–9. CrossRefPubMed
90.
Zurück zum Zitat De Filippis D, D’Amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 2008;20 Suppl 1:20–5. CrossRefPubMed De Filippis D, D’Amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 2008;20 Suppl 1:20–5. CrossRefPubMed
91.
Zurück zum Zitat Shimoda T, Liang Z, Suzuki H, Kawana S. Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells. Clin Exp Dermatol 2010;35:531–6. CrossRefPubMed Shimoda T, Liang Z, Suzuki H, Kawana S. Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells. Clin Exp Dermatol 2010;35:531–6. CrossRefPubMed
92.
Zurück zum Zitat Indraccolo U, Barbieri F. Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations. Eur J Obstet Gynecol Reprod Biol 2010;150:76–9. CrossRefPubMed Indraccolo U, Barbieri F. Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations. Eur J Obstet Gynecol Reprod Biol 2010;150:76–9. CrossRefPubMed
93.
Zurück zum Zitat Joks R, Durkin HG. Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs. Pharmacol Res 2011;64:602–9. CrossRefPubMed Joks R, Durkin HG. Non-antibiotic properties of tetracyclines as anti-allergy and asthma drugs. Pharmacol Res 2011;64:602–9. CrossRefPubMed
94.
Zurück zum Zitat Hesselink JM, Hekker TA. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. J Pain Res 2012;5:437–42. PubMedCentralCrossRefPubMed Hesselink JM, Hekker TA. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. J Pain Res 2012;5:437–42. PubMedCentralCrossRefPubMed
95.
Zurück zum Zitat Bastos LF, de Oliveira AC, Watkins LR, Moraes MF, Coelho MM. Tetracyclines and pain. Naunyn Schmiedebergs Arch Pharmacol 2012;385:225–41. CrossRefPubMed Bastos LF, de Oliveira AC, Watkins LR, Moraes MF, Coelho MM. Tetracyclines and pain. Naunyn Schmiedebergs Arch Pharmacol 2012;385:225–41. CrossRefPubMed
96.
Zurück zum Zitat Grotenhermen F, Müller-Vahl K. Das therapeutische Potenzial von Cannabis und Cannabnoiden. Dtsch Arztebl Int 2012;109:495–501. PubMedCentralPubMed Grotenhermen F, Müller-Vahl K. Das therapeutische Potenzial von Cannabis und Cannabnoiden. Dtsch Arztebl Int 2012;109:495–501. PubMedCentralPubMed
97.
Zurück zum Zitat Oliva SU, Scarano WR, Okada FK, Miraglia SM. Harmful effects of carbamazepine on the postnatal development of the rat ventral prostate. Reprod Biol Endocrinol 2012;10:22. PubMedCentralCrossRefPubMed Oliva SU, Scarano WR, Okada FK, Miraglia SM. Harmful effects of carbamazepine on the postnatal development of the rat ventral prostate. Reprod Biol Endocrinol 2012;10:22. PubMedCentralCrossRefPubMed
98.
Zurück zum Zitat Hu LY, Liu CJ, Lu T, Hu TM, Tsai CF, Hu YW, Shen CC, Chang YS, Chen MH, Teng CJ, Chiang HL, Yeh CM, Su VY, Wang WS, Chen PM, Chen TJ, Su TP. Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study. PLoS One 2013;8:e80064. PubMedCentralCrossRefPubMed Hu LY, Liu CJ, Lu T, Hu TM, Tsai CF, Hu YW, Shen CC, Chang YS, Chen MH, Teng CJ, Chiang HL, Yeh CM, Su VY, Wang WS, Chen PM, Chen TJ, Su TP. Delayed onset urticaria in depressive patients with bupropion prescription: a nationwide population-based study. PLoS One 2013;8:e80064. PubMedCentralCrossRefPubMed
99.
Zurück zum Zitat Ferjan I, Lipnik-Štangelj M. Chronic pain treatment: the influence of tricyclic antidepressants on serotonin release and uptake in mast cells. Mediators Inflamm 2013;2013:340473. PubMedCentralPubMed Ferjan I, Lipnik-Štangelj M. Chronic pain treatment: the influence of tricyclic antidepressants on serotonin release and uptake in mast cells. Mediators Inflamm 2013;2013:340473. PubMedCentralPubMed
100.
Zurück zum Zitat Gurgel JA, Lima-Júnior RC, Rabelo CO, Pessoa BB, Brito GA, Ribeiro RA. Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation. Rev Bras Psiquiatr 2013;35:387–92. CrossRefPubMed Gurgel JA, Lima-Júnior RC, Rabelo CO, Pessoa BB, Brito GA, Ribeiro RA. Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation. Rev Bras Psiquiatr 2013;35:387–92. CrossRefPubMed
Metadaten
Titel
Vermutlich oft gesehen, aber nur selten diagnostiziert
Neurologische und psychiatrische Symptome der systemischen MCAD
verfasst von
Dr. med. Dieter Pöhlau
Prof. Dr. med. Martin Raithel
PD Dr. rer. nat. Britta Haenisch
Dipl.-Phys. Sabrina Harzer
Prof. Dr. med. Gerhard J. Molderings
Publikationsdatum
08.09.2015
Verlag
Urban & Vogel
Erschienen in
NeuroTransmitter / Ausgabe 9/2015
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI
https://doi.org/10.1007/s15016-015-0694-0

Weitere Artikel der Ausgabe 9/2015

NeuroTransmitter 9/2015 Zur Ausgabe

Die Verbände informieren

Immer im Gespräch bleiben!

Die Verbände informieren_Gesundheitspolitische Nachrichten

Zahl der Beschäftigten im Gesundheitswesen steigt weiter an

Die Verbände informieren_Gesundheitspolitische Nachrichten

Positionspapier der Bundesärztekammer

Neu im Fachgebiet Neurologie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Neurologie und bleiben Sie gut informiert – ganz bequem per eMail.